The Wnt receptor, Fzd1, was upregulated in a doxorubicin-resistant neuroblastoma cell line [27], and Fzd1-slienced drug-resistant cells had reduced ABCB1 expression levels and were sensitive to chemotherapeutic treatment [19, 27, 28]. This evidence concerns the gene ABCB1 and neuroblastoma.